Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Exploring the gastrointestinal behavior of dasatinib in healthy volunteers
2019-002944-26Phase 4Terminated
- Sponsor
- KU Leuven
- Start
- Oct 2019
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules, Allosteric Modulators → Classical Binding Small Molecules → Small Molecules, Irreversible Covalent Inhibitors → Covalent Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 4, single-arm trial of dasatinib, sponsored by KU Leuven. Started Oct 2019; status: terminated.
02
Drugs
dasatinib
Beyond the preview
Go deeper on 2019-002944-26.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2019-002944-26.